Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference
CINCINNATI, May 23, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today its participation in the 2022 H.C. Wainwright Global Investment Conference. Jack Kenny, Chief Executive Officer, will pre-record the company’s presentation. A link to Mr. Kenny’s presentation will be posted on May 24, 2022, on the Meridian […]